357 - PEDIATRIC AND CONGENITAL ELECTROPHYSIOLOGY WORKSHOP SERIES PART 2: MANAGING RISK IN PEDIATRIC AND CONGENITAL HEART DISEASE

Saturday, October 25, 2025

3:15pm - 4:15pm ET

Room:303AB

Target Audience: Electrophysiologists, Pediatric cardiologists, Adult congenital cardiologists

Co-Chair(s)

Carolina Escudero, MD, MSc (she/her/hers)

Pediatric Cardiology and Electrophysiology
Stollery Children's Hospital
University of Alberta
AF

Anne Fournier, MD, FRCPC, FCCS

Pediatric Cardiologist
CHU Sainte-Justine

Presenter(s)

Yuval Bitterman, MD (he/him/his)

Staff Physician - Pediatric Electrophysiologist
The Hospital for Sick Children
University of Toronto
Guillaume Leclair, MDCM

University of Saskatchewan

Moderator(s)

Carolina Escudero, MD, MSc (she/her/hers)

Pediatric Cardiology and Electrophysiology
Stollery Children's Hospital
University of Alberta
AF

Anne Fournier, MD, FRCPC, FCCS

Pediatric Cardiologist
CHU Sainte-Justine

Planning Committee Member(s)

Francesca de la Cruz, MD (she/her/hers)

Cardiologist and Electrophysiologist
Children's Hospital of Eastern Ontario
University of Ottawa
SD

Santokh Dhillon, MBBS, MD (he/him/his)

Professor
Dalhousie University
Dalhousie University/IWK Health Center
Carolina Escudero, MD, MSc (she/her/hers)

Pediatric Cardiology and Electrophysiology
Stollery Children's Hospital
University of Alberta
Marisha McClean, MBBS, DM (Paeds)

Pediatric Cardiologist
London Health Sciences Centre
Western University
Cheryl Peters, MD

PEDIATRIC CARDIAC ANESTHESIOLOGIST AND INTENSIVIST
CCS, CANCARE, CPCA
BC Children's Hospital
Jonathan Windram, BSc (Hons), MBChB, MMEd, MRCP (UK), FCCS, FESC

Associate Professor
University of Alberta
Mazankowski Heart Institute

Workshop Description: This is Part 2 of a 3 part workshop series on pediatric and congenital electrophysiology. Part 2 of this series will focus on risk management in children and in patients with congenital heart disease.

Session 1: "What to do with asymptomatic preexcitation”. This session will review the risk of a sudden cardiac event in asymptomatic preexcitation in children, the latest data regarding the yield of non-invasive and invasive risk stratification, and current recommendations regarding risk stratification and ablation in the setting of asymptomatic preexcitation in children.

Session 2: "What's the risk? Updates on sudden death prediction in pediatrics and congenital heart disease”. This session will provide the audience with a review of new risk stratification algorithms and calculators developed for children and patients with congenital heart disease. The limitations of using calculators for risk prediction in non-congenital heart disease in children (including cardiomyopathy) will be discussed.

This part of the workshop will conclude with a question and answer session and panel discussion.

Learning Objectives:

At the end of this session participants will be able to:

Identify the utility and limitations of non-invasive and invasive risk stratification in children with ventricular preexcitation;
Describe the most recent risk calculators available for predicting sudden cardiac death risk in pediatric cardiomyopathy and sudden death risk in patients with congenital heart disease; and
Identify the utility and limitations of using the most recent risk calculators for predicting sudden cardiac death in children and patients with congenital heart disease